Details

Handbook of Hypertension


Handbook of Hypertension


1. Aufl.

von: Mark Houston

89,99 €

Verlag: Wiley-Blackwell
Format: PDF
Veröffentl.: 01.04.2009
ISBN/EAN: 9781444311792
Sprache: englisch
Anzahl Seiten: 412

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan. <p>The <i>Handbook of Hypertension</i> is a comprehensive review of the evidence base for hypertension and associated disease, providing tables, figures, charts, and summaries of principal findings from clinical studies on hypertension – putting vital information within reach of the busy practitioner.</p> <p>Containing the most recent guidelines for global cardiovascular risk analysis and evidence-based reviews on important new advances and recent trials, consulting the <i>Handbook of Hypertension</i> will save precious time and improve patient care.</p>
Provisional Table of Contents. <p><b>Abbreviations</b>.</p> <p><b>General Introduction</b> .</p> <p><b>Introduction</b>.</p> <p>Hypertension Syndrome.</p> <p>Vascular Biology.</p> <p>Functional Endothelium.</p> <p>Endothelial Dysfunction.</p> <p>New Treatment Approach.</p> <p><b>Hypothesis: Essential Hypertension and End-Organ Damage</b>.</p> <p><b>Hypertension Classification and Guidelines Wordwide</b>.</p> <p>Hypertension in the US.</p> <p>JNC-7.</p> <p>NHANES III and IV.</p> <p>CHS.</p> <p>ESH-ESC.</p> <p>ISHIB.</p> <p>AHA.</p> <p>BHS/NICE(RCP).</p> <p>JBS 2.</p> <p><b>Global Cardiovascular Risk Calculation.</b></p> <p><b>Secondary Hypertension.</b></p> <p><b>Measurement of Blood Pressure</b>.</p> <p>Indirect measurement of blood pressure.</p> <p>Korotkoff Sounds.</p> <p>Common Mistakes in Blood Pressure Measurement.</p> <p><b>Hypertension-Atherosclerotic Syndrome.</b></p> <p><b>Normotensive Hypertension.</b></p> <p><b>Pre-hypertension.</b></p> <p><b>Nonpharmacologic Treatment of Hypertension.</b></p> <p>Nutrition.</p> <p>Nutraceuticals, Vitamins, Minerals and Antioxidants.</p> <p>DASH I and II Trials.</p> <p>Specific Recommendations.</p> <p>Obesity.</p> <p>Exercise.</p> <p><b>Approaches to Selection of Antihypertensive Therapy</b>.</p> <p>Stepped Care.</p> <p>Demographics.</p> <p>Subsets of Hypertension.</p> <p>Renin Profiling: The Laragh Method.</p> <p><b>Hemodynamics in Hypertension.</b></p> <p>Hemodynamics: Logical and Preferred Method to Reduce Blood Pressure.</p> <p>Hemodynamic Effects of Antihypertensive Drugs.</p> <p><b>Hypertension-Related End-Organ Damage.</b></p> <p><b>Life Expectancy and Blood Pressure.</b></p> <p><b>Systolic, Diastolic and Pulse Pressure Concepts.</b></p> <p><b>Isolated Systolic Hypertension.</b></p> <p><b>Clinical Hypertension Trials and Antihypertensive</b> .</p> <p><b>Drug</b> <b>Therapy</b> .</p> <p>Completed Trials and Trials in Progress.</p> <p>Diuretic and Beta-Blocker Trials.</p> <p>Summary of Clinical Trials with Diuretics.</p> <p>Summary of Clinical Trials with Beta-Blockers.</p> <p>Meta-Analysis of Various Clinical Trials.</p> <p>Comparisons of ACE-Inhibitor therapy with Placebo.</p> <p>Comparisons of Calcium-antagonist therapy with Placebo.</p> <p>Comparisons of More Intensive Blood Pressure Lowering Strategies with Less.</p> <p>Intensive Strategies.</p> <p>Comparisons of Ace-Inhibitor based Therapy with Diuretic-based or Beta-Blocker Therapy.</p> <p>Comparisons of Calcium-antagonist-based Therapy with Diuretic or Beta-BlockerTherapy.</p> <p>Comparisons of Ace-Inhibitor Therapy with Calcium-antagonist Therapy.</p> <p>Summary of Clinical Trials in Hypertension and Clinical Outcomes.</p> <p>Health Outcomes Meta-Analysis.</p> <p>Comparing the CCBs to other Antihypertensive Therapy.</p> <p>ALLHAT Trial.</p> <p>ALLHAT: Conclusions.</p> <p>ASCOT Trial.</p> <p>Summary of Published Trials Involving CCBs.</p> <p>Angiotensin Converting Enzyme Inhibitors (ACEI) Trials.</p> <p>Summary of ACEI Trials.</p> <p>Angiotensin Receptor Blockers (ARBs) Trials.</p> <p>ARBs Trials Summary.</p> <p><b>Coronary Heart Disease Risk Factor and Effects of Anti-hypertensive Drug Therapy</b>.</p> <p>Coronary Heart Disease: Risk Factors.</p> <p>Coronary Heart Disease Risk Factors: More potential risk factors.</p> <p>Influence of Diuretic and Beta-Blocker Therapy on CHD Risk Factors.</p> <p>Antihypertensive Drugs and Serum Lipids.</p> <p>Summary of Serum Lipids and Antihypertensive Therapy with Diuretics and.</p> <p>Beta Blockers.</p> <p>Effects of Antihypertensive Drugs on Coronary Heart Disease Risk Factors.</p> <p>Antihypertensive Drugs and Coronary Heart Disease Risk Factors: Summary.</p> <p>Calcium Channel Blockers and Atherosclerosis (CHD Reduction Trials).</p> <p><b>Hypertension and Renal Disease</b>.</p> <p>Classification of Chronic Kidney Disease.</p> <p>Hypertension and Renal Damage.</p> <p>Hypertension-Related Renal Damage:.</p> <p>Postulated Mechanisms.</p> <p>Is Thiazide Diuretic-Based Antihypertensive Therapy Associated with Increased.</p> <p>Risk of Renal Injury.</p> <p>Major Clinical Trials Showing Renoprotection.</p> <p>Effects of Antihypertensive Drugs on Renal Function.</p> <p><b>Hypertension and Diabetes Mellitus</b>.</p> <p>Hypertensive Diabetics: Mortality, Coronary Heart Disease and Antihypertensive.</p> <p>Therapy.</p> <p>BP Level Effects on Type II-DM Nephropathy.</p> <p>RENAAL TRIAL.</p> <p>Diabetes Mellitus and Hypertension Summary.</p> <p><b>Selection of Therapy Based on Subsets of Hypertension.</b></p> <p><b>Demographics and Antihypertensive Drugs.</b></p> <p><b>Resistant Hypertension.</b></p> <p><b>Isolated Systolic Hypertension in the Elderly.</b></p> <p><b>Hypertensive Urgencies and Emergencies.</b></p> <p>Treatment; General Principles.</p> <p>Treatment; Choice of Drug.</p> <p>Treatment of Specific Hypertensive Disorders.</p> <p><b>Hypertension in Pregnancy.</b></p> <p><b>General Review of Antihypertensive Drug Therapy.</b></p> <p>Quality of Life and Antihypertensive Therapy (Selected Trials).</p> <p>Antihypertensive Drug Compliance.</p> <p>Total Cost of Antihypertensive Therapy.</p> <p>Characteristics of the Ideal Antihypertensive Drug.</p> <p>Combination Antihypertensive Therapy: Selected Drugs.</p> <p>Combination Antihypertensive Therapy: Selected Drugs: Summary.</p> <p>Antihypertensive Therapy: Efficacy of Monotherapy.</p> <p>Selected Drug Interactions with Antihypertensive Therapy.</p> <p>Maximum Recommended Doses of Antihypertensive Drugs with Best Treatment Characteristics.</p> <p><b>Specific Review of all Antihypertensive Drug Classes</b>.</p> <p>Diuretics.</p> <p>Diuretics Highlights.</p> <p>Central Alpha-Agonists.</p> <p>Central Alpha-Agonists: Similarities.</p> <p>Central Alpha-Agonists: Highlights.</p> <p>Comparison of Commonly Used Oral Central Alpha-Agonists.</p> <p>Postganglionic Neuron Inhibitors.</p> <p>Postganglionic Neuron Inhibitors Highlights.</p> <p>Beta-Blockers—General.</p> <p>Side Effects and Contraindications of Beta-Blockers.</p> <p>Drug Interactions with Beta-Blockers.</p> <p>Beta-Blockers Highlights.</p> <p>Direct Vasodilators.</p> <p>Direct Vasodilators Highlights.</p> <p>Alpha1-Blockers.</p> <p>Alpha1-Blockers: Highlights.</p> <p>Angiotensin-Converting Enzyme (ACE) Inhibitors.</p> <p>Renin-Angiotensin System (RAAS).</p> <p>ACE Inhibitors: Highlights.</p> <p>Non Hypertensive Treatment Effects of ACEIs.</p> <p>Calcium Channel Blockers.</p> <p>Calcium Channel Blockers: Highlights.</p> <p>Treatment: Non Hypertensive Effects of CCBs.</p> <p>Angiotensin II Receptor Blockers (ARBs).</p> <p>Ang-II Receptor Blockers (ARBs): Highlights.</p> <p>Non Hypertensive Treatment effects of ARB’s.</p> <p>Renin Inhibitors.</p> <p>Serum Aldosterone Receptor Antagonists (SARA’s).</p> <p>Combination of Anti-hypertensive Drug with Statin ( Amlodipine with Atorvastatin).</p> <p><b>Arterial Compliance: Structure/Function: Treatment.</b></p> <p><b>Selected Combination Antihypertensive Drugs.</b></p> <p><b>Hypertension Drug Selection: Summary.</b></p> <p><b>New Antihypertensive Drug Classes.</b></p> <p><b>Subset Selection of Antihypertensive Therapy.</b></p> <p><b>Conclusions 383.</b></p> <p><b>References 385.</b></p> <p><b>Index 400.</b></p>
<b>Mark C. Houston</b>, MD, MSc, FACP, FAHA<br /> Associate Clinical Professor of Medicine<br /> Vanderbilt University School of Medicine<br /> ASH Specialist in Clinical Hypertension<br /> Director, Hypertension Institute and Vascular Biology, Nashville, Tennessee<br /> Section Chief, Division of Nutrition and Clinical Research<br /> Staff Physician, Vascular Institute<br /> Saint Thomas Hospital<br /> Nashville, Tennessee
When treating hypertension, physicians now have a huge range of drugs from which to choose in formulating a management strategy. This accessible guide helps the busy clinician access specific information on available drugs as components of an integrated care plan. <p>The <i>Handbook of Hypertension</i> is a comprehensive review of the evidence base for hypertension and associated disease, providing tables, figures, charts, and summaries of principal findings from clinical studies on hypertension – putting vital information within reach of the busy practitioner.</p> <p>Containing the most recent guidelines for global cardiovascular risk analysis and evidence-based reviews on important new advances and recent trials, consulting the <i>Handbook of Hypertension</i> will save precious time and improve patient care.</p>

Diese Produkte könnten Sie auch interessieren:

Biomedical Imaging
Biomedical Imaging
von: Reiner Salzer
PDF ebook
120,99 €
Clinical Reasoning in Occupational Therapy
Clinical Reasoning in Occupational Therapy
von: Linda Robertson
PDF ebook
38,99 €
Clinical Reasoning in Occupational Therapy
Clinical Reasoning in Occupational Therapy
von: Linda Robertson
EPUB ebook
38,99 €